E M Antman, K M Kuntz. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Cost-Benefit AnalysisHumansLength of Stay/economicsMyocardial Infarction/economicsMyocardial Infarction/therapyValue of Life
Year: 2000 PMID: 10717017 DOI: 10.1056/NEJM200003163421109
Source DB: PubMed Journal: N Engl J Med ISSN: 0028-4793 Impact factor: 91.245